In most tissues IGF2 is expressed from the paternal allele while H19 is expressed from the maternal allele. We have previously shown that in some Wilms tumors the maternal IGF2 imprint is relaxed such that the gene is expressed biallelically. We have now investigated this subset of tumors further and found that biallelic expression ofIGF2 was associated with undetectable or very low levels ofH19 expression. The relaxation of IGF2 imprinting in Wilms tumors also involved a concomitant reversal in the patterns of DNA methylation of the maternally inherited IGF2 and H19 alleles. Furthermore, the only specific methylation changes that occurred in tumors with relaxation of IGF2 imprinting were solely restricted to the maternal IGF2 and H19 alleles. These data suggest that there has been an acquisition of a paternal epigenotype in these tumors as the result of a pathologic disruption in the normal imprinting of the IGF2 and H19 genes.
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In humans, several genes are imprinted and monoallelically expressed (1, 2) . Two of these genes, IGF2 and H19, are oppositely imprinted such that IGF2 is expressed from the paternal allele while H19 is expressed only from the maternal allele (3) (4) (5) (6) (7) . IGF2 is an embryonal growth factor; however, the function of H19 is currently not understood, and although H19 RNA is abundantly transcribed in the embryo it does not appear to be translated (8) . The expression patterns of IGF2 and H19 in differentiating human fetal tissues are similar (9, 10) , and because of their close proximity at lip15.5 (11) , it has been proposed that these two genes may form an imprinted domain (1, (11) (12) (13) (14) .
Although the molecular basis of genomic imprinting is yet to be defined, allele-specific DNA methylation has been proposed as the most likely epigenetic mechanism (13, (15) (16) (17) . Recently, we and others have found that in some Wilms tumors the transcriptionally silent maternal IGF2 allele is activated such that IGF2 expression occurs biallelically (3, 4) . A similar biallelic pattern ofIGF2 expression is also seen normally in the choroid plexus and leptomeninges, but both H19 alleles are silent (10) . Conversely, in the methylase-deficient mouse, it has been shown that disruption of DNA methylation leads to the biallelic expression of H19 and an absence of IGF2 expression (14) . Thus, DNA methylation appears to be essential to maintain the normal pattern of imprinting at the IGF2/H19, locus and it is possible that there is a common mechanism that regulates the reciprocal expression of these two genes. There is now evidence to suggest that Hl9 is an unusual class of tumor suppressor gene (18) , which is silenced in some Wilms tumors by DNA methylation (19, 20 (Fig. la) , as has been demonstrated (27, 28) . Unlike IGF2, H19 RNA was detected in only 5/23 tumors, and all of these tumors expressed IGF2 monoallelically (Fig. lb, lanes 8-12) . In contrast to this group of tumors, the expression of H19 was undetectable or very low in 11 tumors that had undergone loss of heterozygosity (LOH) at llpl5 (Fig. lb, lanes 13-23) . These data are consistent with LOH studies in Wilms tumors that show a preferential loss of the maternal llp allele (29) (30) (31) (32) , from which H19 is normally expressed (7) . In a third group of tumors IGF2 was expressed biallelically and the levels of H19 RNA were also very low or undetectable (Fig. lb, lanes 1-7) . These data suggest that in these tumors an epigenetic change on the maternal chromosome has led to the activation of the maternal IGF2 allele and silencing of the maternal H19 allele.
Abbreviation: LOH, loss of heterozygosity. *To whom reprint requests should be addressed.
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To determine whether there was allele-specific methylation of IGF2, the Hpa II-resistant fragments in Fig. 2a (lanes 8-12) were isolated from an agarose gel and amplified by PCR using primers to detect the Apa I or AC repeat polymorphism. As shown in Fig. 3a (lanes 2, 4, and 6 ) and Fig. 3b (lanes 1 and 3) , the Hpa II-resistant fragments were derived from one allele only. This finding contrasts with RNA PCR data, which showed that transcription occurred from the other IGF2 allele-that is, the allele that was not methylated (Fig. 3a, lanes  3 , 5, and 7; Fig. 3b, lanes 2 and 4) . Because IGF2 is transcribed from the paternal allele (3-5, 10), we conclude that the nonexpressed maternal IGF2 allele in these tumors was extensively methylated. This conclusion was formally verified in one case in which parental DNA was available. As shown in Fig. 3b, (Fig. 2a, lanes 1-7) , Hpa II digestion resulted in a limited digest pattern (two fragments of 1.2 and 0.8 kbp) corresponding to that seen with Msp I digestion (Fig. 2a, lanes 17-19) . In contrast to the tumors that expressed IGF2 monoallelically, in these tumors the maternally derived Hpa II-resistant fragments were absent (Fig. 2a, lanes 8-12) . The same pattern was observed with Hha I digestion (Fig. 3b, lanes 1-7) . These data indicate that there was extensive hypomethylation of both IGF2 alleles in tumors in which relaxation of IGF2 imprinting had occurred. Similarly, in tumors with maternal lip LOH (Fig. 2 a and b, lanes 13-16) and another seven tumors (data not shown), the absence of Hpa II-and Hha I-resistant fragments indicates that the retained IGF2 paternal allele was extensively hypomethylated.
Methylation of H19 Alleles in Wilms Tumor. The methylation status of the H19 alleles was also examined. The Southern blot that had previously been probed with an IGF2 cDNA probe (Fig. 2a) was stripped and reprobed with an HI9 cDNA probe. As shown in Fig. 2c (lanes 8-12, arrows) , low molecular weight fragments were present in DNA samples from tumors that expressed IGF2 monoallelically. Since these low molecular weight H19 fragments were not present in the DNA of tumors that had undergone maternal llp LOH (Fig. 2c, lanes  13-16) , this provides evidence that the inactive paternal allele of the H19 gene was methylated. A similar pattern of methylation was found in tumors in which H19 expression was absent and relaxation of IGF2 imprinting had occurred. As shown in Fig. 2c (lanes 1-7) , both alleles of the inactive H19 gene were extensively methylated. These data are consistent with previous work, which showed that the nonexpressed paternal H19 allele is methylated (34) .
Methylation of Other lipi5 Genes in Wilms Tumor. Because altered methylation of some llp genes has been previously observed in human tumors and cell lines (35) , we determined whether these changes were due to a generalized alteration in DNA methylation at llpl5 or confined to the IGF2/H19 locus. As shown in Fig. 4 , after reprobing the Southern membranes used in Fig. 2 with a series of chromosome lip probes, including insulin (Fig. 4a) , HRAS (Fig. 4b) (19, 20) , while here we report that methylation changes encompass the entire IGF2/H19 domain. More importantly, we have addressed the question of the specificity of methylation of these imprinted genes in Wilms tumor. DNA methylation changes at the IGF2 and H19 gene loci could reflect one of the two following situations: (i) the changes in DNA methylation were specific for the IGF2/H19 locus, or (ii) the methylatidn changes were simply a by-product of a generalized alteration in DNA methylation, which is characteristic of many tumors (36) (37) (38) . We have shown that in all Wilms tumors, iipi5 genes were hypermethylated, regardless of the specificity of the methylation pattern at the IGF2/H19 locus. The specificity of the methylation changes of the IGF2 and H19 maternal alleles in tumors in which relaxation of IGF2 imprinting had occurred therefore provides evidence consistent with an epigenetic alteration at this locus being central to the tumorigenesis pathway.
Data suggesting that IGF2 is methylated in an allele-specific manner has previously been reported in one kidney sample; however, the parental origin of methylation and IGF2 imprinting status were not determined (39) . Recently, it was found that a region in exon 9 of the human IGF2 gene is specifically methylated on the paternal allele in peripheral blood and in a variety of tissues from patients with the Beckwith-Wiedemann syndrome (40), but we have been unable to demonstrate a similar pattern of methylation at this site in normal kidney and Wilms tumors (M.J.S., unpublished data). The epigenetic modification of the IGF2 locus that we have detected in Wilms tumors and kidney is not present in all tissues and therefore provides an example of a tissue-specific methylation imprint that is unrelated to gamete-of-origin imprinting. In contrast to these findings, it has been reported that in mouse embryos there is a region of methylation upstream from the paternal IGF2 allele, although exons of both alleles are largely unmethylated (33) . The differences in methylation seen in these mouse tissues and in human kidney and Wilms tumors may be due to variations in tissue-specific methylation imprinting.
IGF2 is expressed monoallelically in most tissues; however, biallelic expression is found in the choroid plexus and leptomeninges where there is also no expression ofHI9 (10, 41, 42) . This finding, together with the close proximity of IGF2 and H19, has led to the suggestion that IGF2 and H19 form a coordinately regulated imprinted domain, which may be controlled by a bidirectionally actingH19 enhancer (1, (11) (12) (13) (14) . The question arises as to the mechanism of the epigenetic changes that lead to relaxation of IGF2 imprinting. Parallels with the XIST gene may provide clues to understanding the events leading to the epigenetic changes at the IGF2/Hl9 locus. For example, H19 and XIST both act in cis, neither of the RNA products appears to be translated, and both genes lie within imprinted regions of the genome (43, 44) . By analogy with XIST and chromosome X inactivation, the function ofH19 may be required to initiate events that lead to inactivation of the IGF2/H19 locus. Accordingly, data shown here which demonstrate that methylation of the human IGF2 gene occurs in a tissue-specific fashion and equates to gene silencing are consistent with IGF2 methylation being secondary to the events that initiate the allele-specific repression of IGF2 transcription.
That H19 may be the primary imprinted gene, the activity of which is required to suppress IGF2 transcription in cis, has previously been suggested to explain the patterns of H19 and IGF2 expression in methylase-deficient mice (14) . Experiments reported here are consistent with the notion that Southern filters of Fig. 2 were stripped and reprobed with insulin (a) and HRAS (b) DNA probes. DNA samples correspond to the same lanes in Fig. 2 
